Capsaicin; Nonanoyl analogue
AlkaPlorer ID: AK002776
Synonym: N-[(4-Hydroxy-3-methoxyphenyl)methyl]nonanamide, N-Vanillylnonanamide, Synthetic capsaicin, Pseudocapsaicin, Pelargonoyl vanillylamide, Nonivamide, PSVA, FEMA 2787, HH 50, AH 23491X, 8-Nordihydrocapsaicin
IUPAC Name: N-[(4-hydroxy-3-methoxyphenyl)methyl]nonanamide
Structure
SMILES: CCCCCCCCC(O)=NCC1=CC=C(O)C(OC)=C1
InChI: InChI=1S/C17H27NO3/c1-3-4-5-6-7-8-9-17(20)18-13-14-10-11-15(19)16(12-14)21-2/h10-12,19H,3-9,13H2,1-2H3,(H,18,20)
InChIKey: RGOVYLWUIBMPGK-UHFFFAOYSA-N
Reference
In vitro propagation of Capsicum chinense Jacq.
PubChem CID: 2998
CAS: 2444-46-4
LOTUS: LTS0228584
SuperNatural Ⅲ: SN0324792
NPASS: NPC93882
COCONUT: CNP0188271
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| None | Capsicum | Solanaceae | Solanales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
| Capsicum annuum | Capsicum | Solanaceae | Solanales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 293.40700000000004
TPSA?: 62.05000000000001
MolLogP?: 4.607900000000004
Number of H-Donors: 2
Number of H-Acceptors: 3
RingCount: 1
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| Bacteria | Cell membrane | Activity | nan | None | 10.1021/acs.jmedchem.2c01604 |
| Cavia porcellus | Cavia porcellus | EC50 | 400.0 | nM | 10.1021/jm00068a014 |
| Cavia porcellus | Cavia porcellus | EC50 | 400.0 | nM | 10.1021/jm00068a015 |
| Equus caballus | Ferritin light chain | Potency | 28183.8 | nM | None |
| Escherichia coli | Escherichia coli | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| Escherichia coli K-12 | Endonuclease 4 | Potency | 707.9 | nM | None |
| Homo sapiens | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Potency | 22387.2 | nM | None |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 25118.9 | nM | None |
| Homo sapiens | Arachidonate 15-lipoxygenase | Potency | 25118.9 | nM | None |
| Homo sapiens | Bile acid receptor FXR | Potency | 25118.9 | nM | None |
| Homo sapiens | Bloom syndrome protein | Potency | 50118.7 | nM | None |
| Homo sapiens | Cytochrome P450 1A2 | AC50 | 12589.25 | nM | None |
| Homo sapiens | Cytochrome P450 2C19 | AC50 | 7943.28 | nM | None |
| Homo sapiens | Cytochrome P450 2C19 | Potency | 7943.3 | nM | None |
| Homo sapiens | Cytochrome P450 2C9 | AC50 | 3162.28 | nM | None |
| Homo sapiens | Cytochrome P450 2C9 | Potency | 3162.3 | nM | None |
| Homo sapiens | Cytochrome P450 2D6 | AC50 | 25118.86 | nM | None |
| Homo sapiens | Cytochrome P450 2D6 | Potency | 25118.9 | nM | None |
| Homo sapiens | Cytochrome P450 3A4 | AC50 | 3981.07 | nM | None |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 3981.1 | nM | None |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 25118.9 | nM | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 7.1 | nM | None |
| Homo sapiens | DNA polymerase iota | Potency | 112201.8 | nM | None |
| Homo sapiens | Glutaminase kidney isoform, mitochondrial | Potency | 10000.0 | nM | None |
| Homo sapiens | HEK293 | CC50 | 62.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 26.52 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 58.83 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 25118.9 | nM | None |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 89125.1 | nM | None |
| Homo sapiens | Peripheral myelin protein 22 | Potency | 8492.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 23715.0 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 33498.3 | nM | None |
| Homo sapiens | Vanilloid receptor | Activity | nan | None | 10.1021/jm030560j |
| Homo sapiens | Vanilloid receptor | Potency | 10.3 | nM | None |
| Homo sapiens | Vanilloid receptor | Potency | 162.9 | nM | None |
| Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| Mus musculus | Mus musculus | ED50 | 5.0 | umol.kg-1 | 10.1021/jm00068a014 |
| Mus musculus | Mus musculus | ED50 | 5.0 | umol.kg-1 | 10.1021/jm00068a015 |
| Mus musculus | Mus musculus | Inhibition | 72.3 | % | 10.1021/jm00070a002 |
| Mus musculus | Mus musculus | Latency | 31.2 | None | 10.1021/jm00070a002 |
| Mus musculus | Mus musculus | Lethality | 50.0 | % | 10.1021/jm00070a002 |
| Mus musculus | Mus musculus | Response | 8.0 | None | 10.1021/jm00070a002 |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Potency | 1584.9 | nM | None |
| Rattus norvegicus | Rattus norvegicus | Analgesia | 17.0 | % | 10.1021/jm00070a002 |
| Rattus norvegicus | Rattus norvegicus | BP | -28.3 | mmHg | 10.1021/jm00033a011 |
| Rattus norvegicus | Rattus norvegicus | DOSE | 0.005 | mg.kg-1 | 10.1021/jm00033a011 |
| Rattus norvegicus | Rattus norvegicus | EC50 | 550.0 | nM | 10.1021/jm00068a014 |
| Rattus norvegicus | Vanilloid receptor | EC50 | 223.0 | nM | 10.1016/j.bmcl.2012.06.059 |
| Rattus norvegicus | Vanilloid receptor | EC50 | 550.0 | nM | 10.1021/jm00068a015 |
| Rattus norvegicus | Vanilloid receptor | EC50 | 550.0 | nM | 10.1021/jm00068a016 |
| Rattus norvegicus | Vanilloid receptor | EC50 | 550.0 | nM | 10.1021/jm960139d |
| Rattus norvegicus | Vanilloid receptor | Ki | 1223.0 | nM | 10.1016/j.bmcl.2012.06.059 |
| Rattus norvegicus | Vanilloid receptor | Ki | nan | None | 10.1016/j.bmcl.2012.06.059 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 4.409 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Hit score | 0.2361 | None | 10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.01 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 6.32 | % | 10.21203/rs.3.rs-23951/v1 |
| Staphylococcus aureus | Staphylococcus aureus | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| None | NON-PROTEIN TARGET | Potency | 3162.3 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 15848.9 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 17782.8 | nM | None |
| None | Unchecked | Ac50 | 0.7943 | uM | None |
| None | Unchecked | Ac50 | 2.239 | uM | None |
| None | Unchecked | AC50 | 794.3 | nM | None |
| None | Unchecked | AC50 | 2238.7 | nM | None |
| None | Unchecked | CC50 | 59.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| None | Unchecked | HC5 | 200.0 | ug ml-1 | 10.1021/acs.jmedchem.2c01604 |
| None | Unchecked | HC50 | 200.0 | ug ml-1 | 10.1021/acs.jmedchem.2c01604 |
| None | Unchecked | Inhibition | nan | % | 10.1038/nchembio873 |
| None | Unchecked | MIC | 50.0 | ug.mL-1 | 10.1021/acs.jmedchem.2c01604 |
| None | Unchecked | Potency | 6309.6 | nM | None |
